Biography
- Associate Professor of Medicine
- Program Leader, GI Medical Oncology
- Indiana University School Of Medicine.
- Center for Computational Biology and Bioinformatics
- Department of Medicine - Hematology/Oncology.
Dr. Masood is a distinguished medical professional with a remarkable journey in the field of oncology. He earned his M.B.B.S and MD degrees from the prestigious Sher-I-Kashmir Institute of Medical Sciences, India, and completed his residency at Wayne State University, Detroit, MI, USA, in 2012. He further honed his expertise through a Post-doctoral fellowship at the University of Maryland Greenebaum Cancer Center, Baltimore, MD, USA, in 2015.
With previous academic roles as an Assistant Professor of Medicine at the University of Missouri-Kansas City School of Medicine (2016-2018) and Washington University School of Medicine in St. Louis (2015-2016), Dr. Masood has garnered extensive experience. He served as the Director of Gastrointestinal Medical Oncology at Rush University Medical College, Chicago, IL, USA, from 2018 to 2021.
Dr. Masood’s areas of expertise encompass gastrointestinal cancer and precision medicine. His deep understanding of computational biology and cancer genomics drives his motivation to pioneer innovative clinical trials in the field of oncology. Notably, he played a pivotal role in the groundbreaking discovery related to “jumping genes” causing colon cancer. Currently, Dr. Masood serves as the Program Leader of GI Medical Oncology at the Indiana University Melvin and Bren Simon Cancer Center.
His significant research contributions are well-documented in high-impact peer-reviewed journals, including the American Association of Cancer Research’s Molecular Cancer Therapeutics, the Journal of Clinical Oncology, and BioMed Central’s Molecular Cancer. Dr. Masood is not only a respected reviewer for top-tier medical journals but also an associate editor for BMC Cancer.
His current research interests are primarily centered around single-cell RNA sequencing and spatial transcriptomics, aiming to push the boundaries of knowledge in the field of oncology. Dr. Masood’s dedication to advancing cancer research and treatment is truly commendable.